e-learning
resources
ERJ
2001
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Burkholderia cepacia: current clinical issues, environmental controversies and ethical dilemmas
Jones A.M., Dodd M.E., Webb A.K.
Source:
Eur Respir J 2001; 17: 295-301
Journal Issue:
February
Disease area:
Interstitial lung diseases, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Jones A.M., Dodd M.E., Webb A.K.. Burkholderia cepacia: current clinical issues, environmental controversies and ethical dilemmas. Eur Respir J 2001; 17: 295-301
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Lung function in epidemiological studies from infancy to childhood with focus on urban environment
Cystic fibrosis and intestinal organoids
Clinics of Cystic Fibrosis Patients with Unusual Bacteria Isolated fromRespiratory Cultures
Related content which might interest you:
Epidemiology of Burkholderia cepacia complex colonisation in cystic fibrosis patients
Source: Eur Respir J 2004; 23: 851-856
Year: 2004
Burkholderia cepacia
complex infection in Czech patients with cystic fibrosis
Source: Eur Respir J 2003; 22: Suppl. 45, 503s
Year: 2003
Cystic fibrosis infection with clonal strains of Pseudomonas aeruginosa: current knowledge and future management
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-46-6, page=105
Year: 2006
Survey of Pseudomonas aeruginosa genotypes in colonised cystic fibrosis patients
Source: Eur Respir J 2006 Oct 01;28(4):740-747
Year: 2006
Cystic fibrosis: the problem with
B. cepacia
and more
Source: Annual Congress 2004 - Lung transplantation: new insights in advanced lung disease and new drug developments - do they impact on selection criteria?
Year: 2004
Cystic fibrosis patients and families support cross-infection measures
Source: Eur Respir J 2004; 24: 449-452
Year: 2004
Pseudomonas aeruginosa in the home environment of newly infected cystic fibrosis patients
Source: Eur Respir J 2008; 31: 822-829
Year: 2008
Melioidosis: an important cause of pneumonia in residents of and travellers returned from endemic regions
Source: Eur Respir J 2003; 22: 542-550
Year: 2003
Achromobacter (A.) xylosoxidans
in cystic fibrosis: prevalence and clinical relevance
Source: Annual Congress 2005 - Cystic fibrosis lung disease: pieces of the puzzle
Year: 2005
The clinical impact of pseudomonas aeruginosa eradication in bronchiectasis in a Dutch center of expertise
Source: International Congress 2018 – Bronchiectasis: phenotypes, endotypes and new therapies
Year: 2018
Epidemiology of Pseudomonas aeruginosa in a cystic fibrosis rehabilitation centre
Source: Eur Respir J 2005; 25: 474-481
Year: 2005
Cystic fibrosis microbiology, emerging pathogens and more treatment options
Source: International Congress 2018 – PG10 Cystic fibrosis: Basic defects and clinical problems in children
Year: 2018
Phenotypic assessment of potential
Burkholderia cepacia
virulence associated determinants
Source: Eur Respir J 2003; 22: Suppl. 45, 503s
Year: 2003
Nebulized heparin in Burkholderia cepacia colonized adult cystic fibrosis patients
Source: Eur Respir J 2001; 17: 36-38
Year: 2001
Molecular epidemiological analysis suggests cross-infection with Pseudomonas aeruginosa is rare in non-cystic fibrosis bronchiectasis
Source: Eur Respir J 2014; 43: 900-903
Year: 2014
The clinical impact of
Pseudomonas aeruginosa
eradication in bronchiectasis in a Dutch referral centre
Source: Eur Respir J, 53 (4) 1802081; 10.1183/13993003.02081-2018
Year: 2019
Pseudomonas aeruginosa
colonisation in patients without bronchiectasis
Source: International Congress 2014 – Clinical management of lung diseases: from bronchi to pleura
Year: 2014
Enterobacteriaceae and Pseudomonas aeruginosa in community-acquired pneumonia: the reality after a decade of uncertainty?
Source: Eur Respir J 2010; 35: 473-474
Year: 2010
Pseudomonas aeruginosa transmission is infrequent in New Zealand cystic fibrosis clinics
Source: Eur Respir J 2008; 32: 1583-1590
Year: 2008
Omics-based tracking of
Pseudomonas aeruginosa
persistence in “eradicated” cystic fibrosis patients
Source: Eur Respir J, 57 (4) 2000512; 10.1183/13993003.00512-2020
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept